These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Long-term outcomes of drug-eluting stents versus bare-metal stents in saphenous vein graft disease: results from the Prairie "Real World" Stent Registry. Goswami NJ; Gaffigan M; Berrio G; Plessa AL; Pfeiffer AM; Markwell SJ; Mishkel GJ Catheter Cardiovasc Interv; 2010 Jan; 75(1):93-100. PubMed ID: 19787803 [TBL] [Abstract][Full Text] [Related]
8. Long drug-eluting stent implantation for a diffusely diseased right internal mammary artery. Niccoli G; Biscione C; Conte M; Crea F J Cardiovasc Med (Hagerstown); 2007 May; 8(5):381-3. PubMed ID: 17443108 [TBL] [Abstract][Full Text] [Related]
9. Snare extraction of a fractured coronary stent in a saphenous vein graft. Steinberg DH; Satler LF; Pichard AD Catheter Cardiovasc Interv; 2007 Aug; 70(2):241-3. PubMed ID: 17377995 [TBL] [Abstract][Full Text] [Related]
11. Vessel diameter should be taken into account in saphenous stenting. Lozano I; Rondan J; Avanzas P EuroIntervention; 2010 Apr; 5(8):991-3. PubMed ID: 20542787 [No Abstract] [Full Text] [Related]
13. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent. Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925 [TBL] [Abstract][Full Text] [Related]
14. Focal in-stent restenosis and in-stent thrombosis within the same bare-metal stent 5 years after deployment in a saphenous vein graft. Ponnuthurai FA; van Gaal WJ; Channon KM J Invasive Cardiol; 2007 Dec; 19(12):E369-71. PubMed ID: 18180530 [TBL] [Abstract][Full Text] [Related]
15. Paclitaxel-eluting stents for chronically occluded saphenous vein grafts (EOS) study. Jim MH; Ho HH; Ko RL; Siu CW; Yiu KH; Lau CP; Chow WH J Interv Cardiol; 2010 Feb; 23(1):40-5. PubMed ID: 20465719 [TBL] [Abstract][Full Text] [Related]
16. Understanding the drug-eluting stent trials. Coolong A; Kuntz RE Am J Cardiol; 2007 Sep; 100(5A):17K-24K. PubMed ID: 17719349 [TBL] [Abstract][Full Text] [Related]
17. Treatment of post-stenotic saphenous vein graft aneurysm: special considerations with the polytetrafluoroethylene-covered stent. Ho PC; Leung CY J Invasive Cardiol; 2004 Oct; 16(10):604-5. PubMed ID: 15505363 [TBL] [Abstract][Full Text] [Related]
18. The MGuard stent: current promises and limitations. Kornowski R Catheter Cardiovasc Interv; 2010 Mar; 75(4):642-3. PubMed ID: 20333654 [No Abstract] [Full Text] [Related]
20. Lack of clinical long-term benefit with the use of a drug eluting stent compared to use of a bare metal stent in saphenous vein grafts. Gioia G; Benassi A; Mohendra R; Chowdhury K; Masood I; Matthai W Catheter Cardiovasc Interv; 2008 Jul; 72(1):13-20. PubMed ID: 18561143 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]